Search results
How Much Upside is Left in Nevro (NVRO)? Wall Street Analysts Think 53.7%
Zacks via Yahoo Finance· 1 year agoThe average of price targets set by Wall Street analysts indicates a potential upside of 53.7% in...
Nevro (NYSE:NVRO) shareholders have endured a 88% loss from investing in the stock three years ago
Simply Wall St. via Yahoo Finance· 8 months agoAs every investor would know, not every swing hits the sweet spot. But really bad investments should...
Strong week for Nevro (NYSE:NVRO) shareholders doesn't alleviate pain of three-year loss
Simply Wall St. via Yahoo Finance· 1 year agoNevro Corp. (NYSE:NVRO) shareholders should be happy to see the share price up 23% in the last...
Insiders may be rethinking their US$2.3m Nevro Corp. (NYSE:NVRO) investment now that the company has...
Simply Wall St. via Yahoo Finance· 2 years agoThe recent price decline of 3.1% in Nevro Corp.'s (NYSE:NVRO) stock may have disappointed insiders...
Here's Why You Should Retain Nevro (NVRO) Stock for Now
Zacks via Yahoo Finance· 3 months agoNevro Corp. NVRO is well-poised for growth in the coming quarters, courtesy of its research and...
Nevro Insiders Still US$51k Away From Original Investment Value
Simply Wall St. via Yahoo Finance· 7 months agoInsiders who bought US$171.6k worth of Nevro Corp. (NYSE:NVRO) stock in the last year recovered part...
Nevro (NVRO) Expected to Beat Earnings Estimates: Should You Buy?
Zacks via Yahoo Finance· 2 years agoNevro (NVRO) possesses the right combination of the two key ingredients for a likely earnings beat...
MedTech Stocks to Watch for Earnings on Aug 1: ECL, NVRO, INSP
Zacks via Yahoo Finance· 11 months agoMedTech companies' Q2 results are likely to reflect strength in customer demand. Let's see how ECL,...
Nevro (NVRO) Reports Q2 Loss, Misses Revenue Estimates
Zacks via Yahoo Finance· 2 years agoNevro (NVRO) delivered earnings and revenue surprises of 12.35% and 0.43%, respectively, for the...
Why Nevro Stock Lagged the Market on Thursday
Motley Fool via Yahoo Finance· 4 months agoSpecialty medical device maker Nevro (NYSE: NVRO) didn't make for an inspiring investment on Thursday. Its stock price dipped marginally following the...
